摘要
摘要
Psychedelics have shown promising antidepressant effects in recent phase 2 randomized controlled trials, with phase 3 studies underway. While therapeutic outcomes are encouraging, the underlying mechanisms-from receptor-level pharmacology to subjective experience and context-remain only partially understood. We highlight clinical and mechanistic advances and outline priorities for future research.
KM 提取结果
0 个 Figure · 0 个 KM 面板